YCM
KYMR icon

Yiheng Capital Management’s Kymera Therapeutics KYMR Stock Holding History

Yiheng Capital Management’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.27M Sell
63,440
-10,000
-14% -$859K 2.5% 14
2026
Q1 		$6.12M Hold
73,440
– – 2.65% 12
2025
Q4 		$5.71M Sell
73,440
-49,165
-40% -$3.32M 1.16% 14
2025
Q3 		$6.94M Hold
122,605
– – 1.02% 15
2025
Q2 		$5.35M Hold
122,605
– – 0.48% 18
2025
Q1 		$3.36M Buy
+122,605
New +$4.47M 0.31% 20

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Yiheng Capital Management's KYMR Position: Q2 2026 in Review

Yiheng Capital Management reduced its Kymera Therapeutics (KYMR) stake by 14% in Q2 2026, selling an estimated $859K and leaving 63,440 shares worth $7.27M. The position accounts for 2.5% of the portfolio, ranked #14.

Yiheng Capital Management first reported a position in KYMR in Q1 2025 and has held it in 6 quarters since. 275 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • Yiheng Capital Management held 63,440 shares of Kymera Therapeutics worth $7.27M as of Q2 2026.
  • Yiheng Capital Management sold 10,000 Kymera Therapeutics shares in Q2 2026, an estimated $859K.
  • Kymera Therapeutics made up 2.5% of Yiheng Capital Management's portfolio in Q2 2026, its #14 holding.
  • Yiheng Capital Management first reported a position in Kymera Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 275 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Yiheng Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.